Adverse Drug Reaction (ADR), Adverse Event (AE), Amendment (to the protocol), Applicable Regulatory Requirement(s), Approval (in relation to Institutional Review Boards), Audit, Audit Certificate, Audit Report, Audit Trail, Blinding/Masking, Case Report Form (CRF), Clinical Trial/Study, Clinical Trial/Study Report, Comparator (Product), Compliance (in relation to trials), Confidentiality, Contract, Coordinating Committee, Coordinating Investigator, Contract Research Organisation (CRO), Direct Access, Documentation, Essential Documents, Good Clinical Practice (GCP), Independent Data-Monitoring Committee (IDMC) (Data and Safety Monitoring Board, Monitoring Committee, Data Monitoring Committee), Impartial Witness, Independent Ethics Committee (IEC), Informed Consent, Inspection, Institution (medical), Institutional Review Board (IRB), Interim Clinical Trial/Study Report, Investigational Product, Investigator, Investigator / Institution, Investigator’s Brochure, Legally Acceptable Representative, Monitoring, Monitoring Report, Multi-centre Trial, Nonclinical Study, Opinion (in relation to Independent Ethics Committee), Original Medical Record, Protocol, Protocol Amendment, Quality Assurance (QA), Quality Control (QC), Randomisation, Regulatory Authorities, Serious Adverse Event (SAE) or Serious Adverse Drug Reaction (Serious ADR), Source Data, Source Documents, Sponsor, Sponsor-Investigator, Standard Operating Procedures (SOPs), Sub-investigator, Subject/Trial Subject, Subject Identification Code, Trial Site, Unexpected Adverse Drug Reaction, Vulnerable Subjects, Well-being (of the trial subjects).